Testing for Haemochromatosis
The first step in testing for haemochromatosis is the assessment of serum iron parameters, which should include transferrin saturation and serum ferritin. 1
Initial Diagnostic Approach
The European Association for the Study of the Liver (EASL) guidelines provide a clear diagnostic pathway for haemochromatosis with 100% consensus on the initial testing approach:
Transferrin saturation (TSAT) is the most sensitive first-line test:
- Values >45% in females and >50% in males warrant further investigation
- Persistently elevated TSAT is particularly concerning
Serum ferritin should be measured simultaneously:
- Elevated levels (>200 μg/L in women, >300 μg/L in men) suggest iron overload
- Levels >1000 μg/L are associated with a high risk (20-45%) of cirrhosis 2
Subsequent Testing
If initial iron studies are abnormal, the diagnostic algorithm proceeds as follows:
Genetic testing:
Additional iron parameters:
Imaging studies:
- MRI should be used to quantify hepatic iron concentrations in cases of:
- Unclear cause of hyperferritinemia
- Biochemical iron overload
- Positive liver iron staining 1
- MRI should be used to quantify hepatic iron concentrations in cases of:
Important Clinical Considerations
Early diagnosis is crucial as phlebotomy therapy can prevent or reverse organ damage 3
Elevated ferritin can occur in various conditions besides haemochromatosis:
- Acute and chronic liver disease
- Systemic inflammatory states
- Secondary iron overload syndromes 3
Diagnosis can be challenging due to uncharacteristic clinical features such as:
Common Pitfalls to Avoid
Relying solely on ferritin levels: Ferritin is an acute phase reactant and can be elevated in inflammatory conditions without true iron overload 2
Missing non-HFE forms: While HFE-related haemochromatosis (particularly C282Y homozygosity) is most common, non-HFE forms exist and may require specialized testing 5
Overlooking confounding factors: Alcohol consumption can exacerbate iron overload and complicate diagnosis 4
Premature liver biopsy: While historically important, non-invasive testing with iron studies and genetic testing should precede invasive procedures 6
Neglecting family screening: Adult first-degree relatives of patients with confirmed haemochromatosis should be tested, as early intervention significantly improves outcomes 7
By following this structured approach to testing for haemochromatosis, clinicians can identify affected individuals early in the disease course, enabling timely intervention that can normalize life expectancy and prevent serious complications.